| Dr Michael T Silver, MD | |
|
1 Northeast Dr, Bangor, ME 04401-4332 | |
| (207) 947-4940 | |
| (207) 941-9400 |
| Full Name | Dr Michael T Silver |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 51 Years |
| Location | 1 Northeast Dr, Bangor, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700857372 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 010671 (Maine) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD10671 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Light Inland Hospital | Waterville, ME | Hospital |
| Maine General Medical Center | Augusta, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Maine Healthcare Systems Inland Hospital | 6305817503 | 75 |
| St Joseph Hospital | 6406766336 | 155 |
News Archive
While emotional barriers such as embarrassment were thought to be the main reason for not attending, this latest study in the Journal of Medical Screening suggests that practical difficulties may be more important.
ARIAD Pharmaceuticals, Inc. today announced that it is discontinuing the Phase 3 EPIC (Evaluation of Ponatinib versus Imatinib in Chronic Myeloid Leukemia) trial of Iclusig (ponatinib) in patients with newly diagnosed chronic myeloid leukemia.
Ontario Shores Centre for Mental Health Sciences (Ontario Shores) is creating a new public website intended to better serve the needs of users and provide opportunities to engage in online dialogue with a variety of stakeholders.
St. Jude Medical, Inc. announced today that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon™ neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from chronic back pain for more than a decade.
Survival from ovarian cancer has almost doubled over the last 30 years according to new figures from Cancer Research UK released today.
› Verified 5 days ago
| Entity Name | St Joseph Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154321545 PECOS PAC ID: 6406766336 Enrollment ID: O20040604000895 |
News Archive
While emotional barriers such as embarrassment were thought to be the main reason for not attending, this latest study in the Journal of Medical Screening suggests that practical difficulties may be more important.
ARIAD Pharmaceuticals, Inc. today announced that it is discontinuing the Phase 3 EPIC (Evaluation of Ponatinib versus Imatinib in Chronic Myeloid Leukemia) trial of Iclusig (ponatinib) in patients with newly diagnosed chronic myeloid leukemia.
Ontario Shores Centre for Mental Health Sciences (Ontario Shores) is creating a new public website intended to better serve the needs of users and provide opportunities to engage in online dialogue with a variety of stakeholders.
St. Jude Medical, Inc. announced today that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon™ neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from chronic back pain for more than a decade.
Survival from ovarian cancer has almost doubled over the last 30 years according to new figures from Cancer Research UK released today.
› Verified 5 days ago
| Entity Name | Eastern Maine Healthcare Systems Inland Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376579557 PECOS PAC ID: 6305817503 Enrollment ID: O20040802001656 |
News Archive
While emotional barriers such as embarrassment were thought to be the main reason for not attending, this latest study in the Journal of Medical Screening suggests that practical difficulties may be more important.
ARIAD Pharmaceuticals, Inc. today announced that it is discontinuing the Phase 3 EPIC (Evaluation of Ponatinib versus Imatinib in Chronic Myeloid Leukemia) trial of Iclusig (ponatinib) in patients with newly diagnosed chronic myeloid leukemia.
Ontario Shores Centre for Mental Health Sciences (Ontario Shores) is creating a new public website intended to better serve the needs of users and provide opportunities to engage in online dialogue with a variety of stakeholders.
St. Jude Medical, Inc. announced today that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon™ neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from chronic back pain for more than a decade.
Survival from ovarian cancer has almost doubled over the last 30 years according to new figures from Cancer Research UK released today.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael T Silver, MD 1 Northeast Dr, Bangor, ME 04401-4332 Ph: (207) 947-4940 | Dr Michael T Silver, MD 1 Northeast Dr, Bangor, ME 04401-4332 Ph: (207) 947-4940 |
News Archive
While emotional barriers such as embarrassment were thought to be the main reason for not attending, this latest study in the Journal of Medical Screening suggests that practical difficulties may be more important.
ARIAD Pharmaceuticals, Inc. today announced that it is discontinuing the Phase 3 EPIC (Evaluation of Ponatinib versus Imatinib in Chronic Myeloid Leukemia) trial of Iclusig (ponatinib) in patients with newly diagnosed chronic myeloid leukemia.
Ontario Shores Centre for Mental Health Sciences (Ontario Shores) is creating a new public website intended to better serve the needs of users and provide opportunities to engage in online dialogue with a variety of stakeholders.
St. Jude Medical, Inc. announced today that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon™ neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from chronic back pain for more than a decade.
Survival from ovarian cancer has almost doubled over the last 30 years according to new figures from Cancer Research UK released today.
› Verified 5 days ago
Eddy Karnabi, MD PHD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Northeast Dr, Bangor, ME 04401 Phone: 207-275-3800 | |
Dr. Theodore William James, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 417 State St Ste 121, Bangor, ME 04401 Phone: 207-973-4266 | |
Fnu Kaleemullah, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 489 State St, Bangor, ME 04401 Phone: 207-973-7314 | |
Sverrir I Gunnarsson, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Northeast Dr, Bangor, ME 04401 Phone: 207-275-3800 | |
Liga Yusvirazi, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 360 Broadway, Bangor, ME 04401 Phone: 207-907-3283 | |
Ilsa Annetta Shulman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 900 Broadway, Bangor, ME 04401 Phone: 207-907-3300 Fax: 207-907-1923 | |
Dr. Michael Paul Sighinolfi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 360 Broadway Ste 100, Bangor, ME 04401 Phone: 207-907-3550 Fax: 207-907-3562 |